Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rejection of Kidney Allograft”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Testing effectiveness (Phase 2)Ended earlyNCT00568477
What this trial is testing

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

Who this might be right for
GraftingRenal TransplantationTransplantation, Kidney+1 more
Technical University of Munich 200
Not applicableLooking for participantsNCT06314230
What this trial is testing

Australian Genomics Of Chronic Allograft Dysfunction Study

Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Western Sydney Local Health District 500
Testing effectiveness (Phase 2)Study completedNCT05983770
What this trial is testing

Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 127
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Testing effectiveness (Phase 2)WithdrawnNCT00261547
What this trial is testing

Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients

Who this might be right for
Chronic RejectionKidney Insufficiency
Massachusetts General Hospital
Not applicableNot Yet RecruitingNCT05890430
What this trial is testing

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

Who this might be right for
Kidney TransplantationKidney Allograft BiopsyHumoral Rejection+1 more
University Hospital, Strasbourg, France 570
Not applicableStudy completedNCT03582436
What this trial is testing

Rejection Diagnosis in Kidney Transplants Patients

Who this might be right for
Kidney TransplantationTransplant RejectionGraft Survival
Assistance Publique - Hôpitaux de Paris 824
Not applicableStudy completedNCT00056784
What this trial is testing

The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Testing effectiveness (Phase 2)Study completedNCT01536379
What this trial is testing

Belimumab in the Prevention of Kidney Transplant Rejection

Who this might be right for
Transplantation, Organ
GlaxoSmithKline 30
Not applicableStudy completedNCT05747274
What this trial is testing

SRDK0921_ Analytical Performance Study

Who this might be right for
Kidney Transplant Rejection
BioMAdvanced Diagnostics 439
Large-scale testing (Phase 3)Looking for participantsNCT04877288
What this trial is testing

Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Who this might be right for
Renal Allograft Recipients
Bristol-Myers Squibb 102
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Post-approval studies (Phase 4)Study completedNCT01649427
What this trial is testing

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Who this might be right for
Pharmacokinetics Study in de Novo Kidney Transplantation
Novartis Pharmaceuticals 73
Not applicableEnded earlyNCT01296061
What this trial is testing

Kidney Transplant Failure

Who this might be right for
Acute Graft RejectionRenal Failure Chronic Requiring Dialysis
Ottawa Hospital Research Institute 270
Testing effectiveness (Phase 2)Study completedNCT00365846
What this trial is testing

"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

Who this might be right for
Renal Transplant
University of Wisconsin, Madison 29
Testing effectiveness (Phase 2)WithdrawnNCT01649388
What this trial is testing

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

Who this might be right for
Kidney Transplantation
Talaris Therapeutics Inc.
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Post-approval studies (Phase 4)Study completedNCT00363116
What this trial is testing

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

Who this might be right for
Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
University of Cincinnati 298
Load More Results